MedRhythms is a digital therapeutics platform. The company uses sensors, music, and other software to improve walking in patients with neurological conditions or diseases.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 07/29/21 | $25,000,000 | Series B |
Advantage Capital Morningside Venture Werth Family Investment Associates | undisclosed |
